MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.

@article{Wang2013MicroRNA29aPA,
  title={MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.},
  author={F. Wang and Pei-Chin Chuang and Chung-Liang Lin and M. Chen and Huei-Jin Ke and Y. Chang and Y. Chen and Shin-Long Wu and J. Ko},
  journal={Arthritis and rheumatism},
  year={2013},
  volume={65 6},
  pages={
          1530-40
        }
}
  • F. Wang, Pei-Chin Chuang, +6 authors J. Ko
  • Published 2013
  • Chemistry, Medicine
  • Arthritis and rheumatism
    • OBJECTIVE Excessive glucocorticoid treatment increases the incidence of osteopenia and osteonecrosis. MicroRNAs (miRNAs) reportedly target messenger RNA expression and regulate osteoblastogenesis and skeletal development. We undertook this study to investigate whether miR-29a regulates glucocorticoid-mediated bone loss. METHODS Rats were given methylprednisolone, lentivirus-mediated miR-29a precursor, or lentivirus-mediated miR-29a inhibitor. Dual x-ray absorptiometry, micro-computed… CONTINUE READING
    View on PubMed
    onlinelibrary.wiley.com
    97 Citations
    Highly Influencial Citations
    4
    Background Citations
    42
    Methods Citations
    2
    Results Citations
    3
    97 Citations
    Citation Type

    Citation Type

    Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
    • 31
    • PDF
    Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans
    • 19
    • Highly Influenced
    MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.
    • 48
    Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis
    • 13
    • PDF
    miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway
    • 82
    • PDF
    Icariin ameliorates dexamethasone-induced bone deterioration in an experimental mouse model via activation of microRNA-186 inhibition of cathepsin K
    • 19
    • PDF
    oration in glucocorticoid-induced osteoporosis (GIOP) mice, and the anti-osteoporosis effect and underlying molecular mechanism of icariin. Dexamethasone (DSM) treatment was demonstrated to facilitate the induction of hypercalciuria in GIOP mice. Icariin treatment reversed the dexametha- sone (DXM)-
    • 2017
    Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2.
    • 23
    Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.
    • 16
    Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development
    • 1
    • PDF

    References

    SHOWING 1-10 OF 47 REFERENCES
    Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis.
    • 22
    Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
    • 21
    Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
    • 154
    • PDF
    Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
    • 92
    Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.
    • 191
    miR‐29 suppression of osteonectin in osteoblasts: Regulation during differentiation and by canonical Wnt signaling
    • 230
    Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
    • 170
    Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis.
    • 38
    Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
    • 103
    • PDF
    Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees.
    • 81